Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (135)
  • Open Access

    ABSTRACT

    The 5th Asian Associations for Pediatric and Congenital Heart Surgery Annual Meeting, Indonesia (AAPCHS 2025)

    Congenital Heart Disease, Vol.20, Suppl.1, pp. 1-49, 2025

    Abstract This article has no abstract. More >

  • Open Access

    ARTICLE

    ETS Family Transcription Factors in Gastric Cancer and the Role of ELF3 in the Core Metaplasia Transcription Factor Network

    Ioannis A. Voutsadakis1,2,3,*

    Oncology Research, Vol.33, No.12, pp. 4073-4092, 2025, DOI:10.32604/or.2025.069230 - 27 November 2025

    Abstract Background: E26 transformation-specific (ETS) family transcription factors have confirmed roles in several types of cancers. This study aimed to clarify the role of ETS family transcription factor alterations in gastric cancers. Methods: This study examines molecular alterations of ETS transcription factors in gastric adenocarcinomas based on an analysis of publicly available cohorts from the Protein Atlas and the Cancer Genome Atlas. The expression and relationships of members of the ETS transcription factor family with other important factors in the process of gastric carcinogenesis were evaluated using the same resources. Results: mRNA expression levels of ETS family… More >

  • Open Access

    ARTICLE

    Tranexamic acid and hematuria outcomes following aquablation for benign prostatic hyperplasia

    Phillip Taboada1, Rohit R. Badia1, Dhillon Advano1, Andrew Murphy1, Christina Sze1, Ryan J. Mauck1, Jennifer Tse1, Jeffrey Gahan2, Claus G. Roehrborn1, Ramy Goueli1,*

    Canadian Journal of Urology, Vol.32, No.5, pp. 491-499, 2025, DOI:10.32604/cju.2025.068150 - 30 October 2025

    Abstract Background: Aquablation is a robotic-assisted, water jet-based transurethral therapy for benign prostatic hyperplasia (BPH). Concerns about postoperative hematuria led to the practice of limited transurethral resection (TUR) with cauterization. This study aimed to assess the impact of tranexamic acid (TXA) on hematuria outcomes when combined with limited TUR after Aquablation. Methods: We retrospectively analyzed men undergoing Aquablation at our institution (October 2020–July 2024). Demographic, prostate, surgical, and hematuria outcomes were extracted from electronic medical records. Kruskal-Wallis test compared medians. Results: Of 131 patients, 113 (86%) had limited TUR; 31 (27%) received 1 g TXA perioperatively. TXA… More >

  • Open Access

    ARTICLE

    Correlation between chronic prostate inflammation and overactive bladder symptoms following transurethral resection of the prostate due to benign prostate hyperplasia

    Ozgu Aydogdu1,*, Onur Erdemoglu2, Halil Ibrahim Bozkurt2, Tansu Degirmenci2, Michael Winder3

    Canadian Journal of Urology, Vol.32, No.5, pp. 529-538, 2025, DOI:10.32604/cju.2025.064564 - 30 October 2025

    Abstract Objectives: Treatment of patients with lower urinary tract symptoms (LUTS) is often challenging. In men, the origin of LUTS, in particular overactive bladder (OAB) symptoms, is often due to prostate enlargement. However, patients with chronic prostate inflammation (CPI) also frequently experience OAB. Thus far, it is not known if the inflammation per se or concomitant prostate enlargement is the underlying cause of LUTS. Currently, we aim to examine if there is any correlation between CPI and the persistence of OAB symptoms in patients with benign prostate hyperplasia (BPH). Methods: Fifty-one men underwent transurethral resection of… More >

  • Open Access

    REVIEW

    Topical Chemotherapy for Ocular Surface Squamous Neoplasia: A Review of Adverse Effects and Their Clinical Management

    Lina Corgiolu, Giuseppe Giannaccare*, Alberto Cuccu

    Oncology Research, Vol.33, No.10, pp. 2725-2740, 2025, DOI:10.32604/or.2025.067221 - 26 September 2025

    Abstract Topical chemotherapy is increasingly used to treat ocular surface tumors as a primary therapy and an adjuvant treatment after surgical excision. The most employed topical agents include mitomycin C (MMC), 5-fluorouracil (5-FU), and interferon alpha-2b (IFNα2b), each with distinct mechanisms of action, efficacy profiles, and toxicity risks. Although these agents offer effective tumor control and allow for a non-invasive approach in many cases, ocular surface complications requiring medical or surgical management can occur. This summarizes the adverse effect and outilines practical strategies for their prevention and treatment. MMC is the most potent agent but also… More >

  • Open Access

    REVIEW

    Crosstalk between mitochondrial dysfunction and benign prostatic hyperplasia: unraveling the intrinsic mechanisms

    Huan Liu1,#, Yan Li2,#, Jizhang Qiu1, Junchao Zhang1, Huan Lai1, Xinhua Zhang1,*

    Canadian Journal of Urology, Vol.32, No.4, pp. 255-269, 2025, DOI:10.32604/cju.2025.066523 - 29 August 2025

    Abstract Benign prostatic hyperplasia (BPH) represents a prevalent etiology of lower urinary tract symptoms (LUTS) in the male population, clinically defined by a non-malignant proliferation of prostatic tissue. While BPH exhibits a high prevalence among older male populations globally, the precise underlying mechanisms contributing to its development remain incompletely elucidated. Mitochondria, essential organelles within eukaryotic cells, are critical for cellular bioenergetics, the regulation of reactive oxygen species (ROS) generation, and the modulation of cell death pathways. The maintenance of mitochondrial homeostasis involves a complex interplay of processes. By synthesizing previous literature, this review discusses mitochondrial homeostasis More >

  • Open Access

    ARTICLE

    Impact of metabolic syndrome on combination therapy efficacy in LUTS due to BPH: a prospective study

    Iqbal Singh1,*, Himanshu Agrawal2, Vidhi Maurya2, Sanjay Gupta2, Alpana Raizada3

    Canadian Journal of Urology, Vol.32, No.4, pp. 299-308, 2025, DOI:10.32604/cju.2025.064827 - 29 August 2025

    Abstract Objectives: Benign prostatic hyperplasia (BPH) is a common benign tumor in men, with an age-related prevalence of multifactorial etiology. The present study aimed to accurately assess and predict the effect of co-existing metabolic syndrome (MtS) upon treatment outcomes of combination medical therapy in select patients of lower urinary tract symptoms (LUTS) due to BPH. Methods: After obtaining informed consent from the patients, 70 eligible patients with LUTS due to BPH with and without MtS were enrolled in this study from September 2022 to January 2024 from the outpatient clinic at the University College of Medical… More >

  • Open Access

    ARTICLE

    How I do it: percutaneous cystolitholapaxy for bladder stones with complex lower urinary tract anatomy

    Matthew S. Lee, Trey R. Sledge, Amanda K. Seyer, Robert Qi, Kevin Koo*

    Canadian Journal of Urology, Vol.32, No.4, pp. 325-333, 2025, DOI:10.32604/cju.2025.064255 - 29 August 2025

    Abstract While cystolitholapaxy for bladder stones is commonly performed using a transurethral approach, large or complex stone burdens in patients with complex lower urinary tract anatomy may make this inefficient or infeasible. Percutaneous cystolitholapaxy is a safe, effective, minimally invasive alternative for diverse indications, including patients with benign prostatic hyperplasia, urethral stricture disease, closed bladder neck, continent catheterized channel, or other urinary diversion. In this article, we review the indications for and advantages of percutaneous cystolitholapaxy and describe our step-by-step technique for this procedure, including representative imaging and favored equipment. We also discuss preoperative and postoperative More >

  • Open Access

    ARTICLE

    Reprogramming the Metabolome of Centella asiatica (L.) Urban Callus: Profiling of Newly Synthesized Cryptic Anthocyanins Triggered by LED Light Exposure

    Claude Y. Hamany Djande, Paul A. Steenkamp, Ian A. Dubery*

    Phyton-International Journal of Experimental Botany, Vol.94, No.4, pp. 1269-1286, 2025, DOI:10.32604/phyton.2025.062392 - 30 April 2025

    Abstract Centella asiatica L., a medicinal herb, has attracted substantial interest in research as well as commercial domains due to its bioactive compounds which include the pentacyclic triterpenoid centellosides, and in addition, hydroxy. In addition, hydroxycinnamic acid conjugates as well as flavonoids. The latter is the major class of secondary plant metabolites and comprises various subclasses, including anthocyanidins. Anthocyanins are rarely reported in extracts from C. asiatica and differ structurally due to a flavylium (2-phenylchromenylium) ion that carries a positive charge at the oxygen atom of the C-ring of the basic flavonoid structure. Callus of C. asiatica was initiated… More >

  • Open Access

    ARTICLE

    Improving Hornet Detection with the YOLOv7-Tiny Model: A Case Study on Asian Hornets

    Yung-Hsiang Hung, Chuen-Kai Fan, Wen-Pai Wang*

    CMC-Computers, Materials & Continua, Vol.83, No.2, pp. 2323-2349, 2025, DOI:10.32604/cmc.2025.063270 - 16 April 2025

    Abstract Bees play a crucial role in the global food chain, pollinating over 75% of food and producing valuable products such as bee pollen, propolis, and royal jelly. However, the Asian hornet poses a serious threat to bee populations by preying on them and disrupting agricultural ecosystems. To address this issue, this study developed a modified YOLOv7tiny (You Only Look Once) model for efficient hornet detection. The model incorporated space-to-depth (SPD) and squeeze-and-excitation (SE) attention mechanisms and involved detailed annotation of the hornet’s head and full body, significantly enhancing the detection of small objects. The Taguchi… More >

Displaying 1-10 on page 1 of 135. Per Page